Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
about
A novel role for MAPKAPK2 in morphogenesis during zebrafish developmentThe kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinaseMechanism of activation of protein kinase B by insulin and IGF-1Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREBMNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substratesPRAK, a novel protein kinase regulated by the p38 MAP kinaseAn analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitroMitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylationPhosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivoThe p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factorActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinases3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathwaysIdentification of sites phosphorylated by the vaccinia virus B1R kinase in viral protein H5RTargeting the Checkpoint to Kill Cancer CellsMolecular basis of MAPK-activated protein kinase 2:p38 assemblyScaffolding by ERK3 regulates MK5 in developmentmiR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cellsERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functionsSerotonin Receptor 4/6/7 and NR3C SignalingSerotonin Receptor 2 and ELK-SRF/GATA4 signalingRational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study.MAPK-activated protein kinase 2 is required for mouse meiotic spindle assembly and kinetochore-microtubule attachment.Stress signaling and the shaping of the mammary tissue in development and cancer.Endothelial nitric oxide synthase is regulated by ERK phosphorylation at Ser602.p38α MAPK is a MTOC-associated protein regulating spindle assembly, spindle length and accurate chromosome segregation during mouse oocyte meiotic maturation.Polycyclic aromatic hydrocarbon-induced signaling events relevant to inflammation and tumorigenesis in lung cells are dependent on molecular structure.Mitogen-activated protein kinase signalling and ERK1/2 bistability in asthma.Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.Twitchin kinase interacts with MAPKAP kinase 2 in Caenorhabditis elegans striated muscle.MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation.Reactive Oxygen Species, SUMOylation, and Endothelial InflammationPhosphorylation of the RNA-binding protein Dazl by MAPKAP kinase 2 regulates spermatogenesis.TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.p38 mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 (MK2) signaling in atrophic and hypertrophic denervated mouse skeletal muscleTargeting Mnks for cancer therapy.
P2860
Q21563346-7EA6FAD0-2D1A-4A42-9F50-9622D050C906Q24291138-20DCC6C3-B8CB-467C-80AB-21E927101ED1Q24309528-90E092FF-90FE-48A5-ADBD-DCC139D1635FQ24319704-186AFB28-7BA7-49E2-BCA0-360533FB9F91Q24322852-22D87ECE-E40D-4D79-A684-A7974C8D9CB8Q24336112-D246542A-D2A8-4D6B-8EEE-48A43D53E7E8Q24529982-19705597-FC6D-4029-ADB3-CA8FD057BBC0Q24532154-BCE2B72E-C5CC-4A1C-8CD1-AF99200C7385Q24533258-F09B3C93-EF55-4463-834A-FEA03CD04615Q24554527-67385247-51A8-4DE0-A638-DF35458901DDQ24563111-1E9A31FD-AF6B-4003-AE12-4EC785D92200Q24632768-873BA82E-5D5B-40D5-AD0F-A154A1DF86FFQ24647721-FCA4EF74-CF2F-42D2-8223-8F05DDC583E9Q24795211-AA0AF4B8-7C77-47AD-884C-147F4D1B3BE7Q26795781-D7118D2D-BC62-49A4-B325-17C88EC7C672Q27644283-457F919F-0292-42BE-B992-F2F001ACE30BQ28587317-39E7564B-8F2A-47EF-9791-6C124D6BE9C5Q28829677-2F2B5539-7810-495D-8C79-46DECC6269E1Q29615216-5E492261-392C-45E1-8AAA-C61CA354AE64Q30230753-8B09413C-AC9E-4148-B702-1892752A2F38Q30230906-D2271CF9-E4AE-4AF9-B0E4-31E2C0519EBBQ33419516-5A017F23-B12D-4489-A300-0F181A0AE8EEQ33623712-7E459408-7E9D-4B47-B3E6-DA3ADC6DF4E7Q33896062-16DCB2CD-772A-4CD7-A608-D777636E42CBQ34197487-64850652-2F23-406C-B335-3A491CE59828Q34659879-B370471A-914E-4E54-99C6-6F35B1045F4CQ34766134-CD344551-F463-4535-A1B2-15ABCA55CFA7Q35047271-31DBB6DC-82F9-483B-9955-9771FF4139DCQ35157014-8ABEFC51-0758-40D0-8014-BD26BCC29DA5Q35230062-A618B51D-CC2C-4CE6-8E80-789D66709D41Q35617873-703A51B3-7B35-4DAA-B640-A9C08D606768Q35754884-DD06963B-D9C0-4CBD-9132-134696EDC1D0Q36229545-642C9469-A1A1-42F1-9BB2-6A0EB5C1A166Q36237663-53EE6ACA-E4CC-4F1C-9BC6-B5CF3931B06FQ37139151-BC27C947-CF1B-4120-A211-CE4700783CF0Q37219806-626139CA-29FF-4EEF-8214-E0260881FA93Q37342444-80BF772C-952C-459E-ACDC-05F3C2F08072Q37364533-05B3DDBB-3F22-49D8-B6D4-FCD1639D8AB0Q37716475-EBE01A1E-D07F-42D2-85B6-A67740C28F32Q37990881-A0F96F82-1F3E-4C08-870F-2138A89BDC8C
P2860
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@ast
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en-gb
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@nl
type
label
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@ast
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en-gb
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@nl
prefLabel
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@ast
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en-gb
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@nl
P2093
P2860
P921
P3181
P1433
P1476
Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
@en
P2093
Ben-Levy R
Leighton IA
Marshall CJ
P2860
P304
P3181
P356
10.1002/J.1460-2075.1995.TB00280.X
P407
P577
1995-12-01T00:00:00Z